Biodefense Market Size to Reach USD 20.13 Billion in 2028 | Rapid Advancements in the Field of Biotechnology and Availability of Advanced Biothreat Detection Devices are Some Key Factors Driving Industry Demand, According to Emergen Research
VANCOUVER, BC, Jan. 24, 2022 /PRNewswire/ -- The global biodefense market size was USD 13.08 Billion in 2020. Rising public awareness regarding natural and synthetic biological threats and increased investments by governments in developed and developing countries on research and development activities are some key factors driving market revenue growth.
Drivers: Technological advancements in biotechnology
Rapid advancements in biotechnology has enabled production of biological weapons with unique and unpredictable characteristics. Emergence of innovations and newer technologies such as in nanotechnology, microbiology, and genetic engineering have helped to develop new vaccines and strategies to tackle biothreats. Biotechnology provides critical capabilities in defense against natural and man-made biothreats. Latest developments in biochemical detectors for recognition of biological targets, including measurement of products and enzymatic activities, and advancements in biothreat detector devices are other key factors driving revenue growth of the biodefense market.
Restraints: Low market penetration in developing and underdeveloped countries
Low market penetration and insubstantial government intervention and funding, especially in underdeveloped countries, for biodefense products are some major factors hampering growth of the market. In addition, continuous increasing population in developing countries along with existing health and economic crisis are some other key factors restraining growth of the market to a significant extent.
Get Free Sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/905
Growth Projections
Global biodefense market size is expected to reach USD 20.13 Billion in 2028 and register a revenue CAGR of 5.4% over the forecast period, according to the latest report by Emergen. Favorable government initiatives, rise in demand for biodefense products, and increasing incidence of infectious diseases are factors driving biodefense market revenue growth.
COVID-19 Direct Impact
The COVID-19 pandemic has adversely affected market growth. Schools and universities closed and transitioned online for several months. Various countries registered mutations of the virus, which resulted in extension of lockdowns in pockets, especially in some emerging countries. This showed that governments of various countries were not prepared for medical emergency such as the COVID-19 pandemic. The pandemic also emphasized the importance of strong biodefense capabilities. Due to outbreaks of COVID-19, Nipah, and Ebola virus, governments of different countries are investing substantially in research and development to develop and store more COVID-19 and other vaccines, and the trend is expected to continue for the next few years.
Current Trends and Innovations
Advancements in biodefense technologies and innovations such as genetic engineering is boosting growth of the biodefense market. With the advent of genome engineering, the ability to manipulate bacteria and viruses at the molecular level has reached its greatest achievement. This has also opened up high potential for development of more superior and highly dangerous biological weapons. Genetic engineering also makes existing pathogens more transmissible, which is enhancing the potential of biological weapons, therefore making them more dangerous. Moreover, as biological agents are self-replicating, they can be transmitted from person to person making potential attack even greater.
Looking for Discount on Biodefense market report [Click Here]@ https://www.emergenresearch.com/request-discount/905
Geographical Outlook
Market in North America accounted for a significantly robust revenue share in 2020 owing to investments undertaken by the U.S. government for achieving medical preparedness against biological warfare. Furthermore, rapid technological advancements in the fields of biotechnology and nanotechnology is further expected to boost revenue growth of the market.
Market in Asia Pacific registered a significantly robust revenue share in 2020 and is expected to register a rapid growth rate over the forecast period. Rapidly expanding pharmaceuticals industry and increasing investment by countries such as China, Japan, and India in biodefense is driving market growth in this region.
Strategic Initiatives
In July 2020, Emergent BioSolutions Inc., ImmunoTek Bio Centers, LLC, and The Mount Sinai Health System announced their collaboration to develop, manufacture, and conduct clinical trials to evaluate Hyperimmune Globulin (COVID-HIG), funded by the U.S government. This collaboration will enhance response to COVID-19 in front line healthcare workers and will protect numerous lives.
Some Key Highlights From the Report
- Anthrax segment accounted for largest revenue share in 2020 and is expected to register a rapid rate over the forecast period owing to increasing funding by governments of various countries to develop and stockpile adequate vaccines against anthrax, mainly through a variety of initiatives such as BioShield Act, Biomedical Advanced Research and Development Authority (BARDA), and the Joint Program Executive Office for Chemical & Biological Defense.
- Military segment accounted for largest revenue share in 2020 and is expected to register fastest growth rate during the forecast period owing to direct and indirect support from governments to ensure regional security. Research and development backed by military in the field of biotechnology have laid the foundation for improvements in vaccine development processes.
- Sampler segment accounted for moderate revenue share in 2020 and is expected to register a steady growth rate over the forecast period. Sampler helps to improve clinical outcome of a medical diagnosis.
- Some major companies included in the global market report are CanSino Biologics, BioNTech SE, Altimmune, Emergent BioSolutions Inc., SIGA Technologies, Inc., Cleveland BioLabs, Inc., Alnylam Pharmaceuticals Inc., Elusys Therapeutics, DynPort Vaccine Company LLC, and Ichor Medical Systems Inc., AstraZeneca Plc, Serum Institute of India, Wuhan Institute of Biological Products, Inovio Pharmaceuticals Inc., and Sinovac Biotech Ltd.
Explore Complete Report Description and Table of Contents of Biodefense Market Report@ https://www.emergenresearch.com/industry-report/biodefense-market
Emergen Research has segmented the global biodefense market on the basis of product type, biothreat detection device type, end-use, and region:
- Product Type Outlook (Revenue, USD Billion; 2018–2028)
- COVID-19 Vaccine
- Anthrax Vaccine
- Smallpox Vaccine
- Botulism Vaccine
- Others
- Biothreat Detection Device Type Outlook (Revenue, USD Billion; 2018-2028)
- Sampler
- Triggering Devices
- Identifier
- Others
- End-use Outlook (Revenue, USD Billion; 2018–2028)
- Hospital and Clinics
- Ambulatory Care Centre
- Research Organizations
- Military
- Others
Buy Your Exclusive Copy@ https://www.emergenresearch.com/select-license/905
- Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- a. U.S.
- b. Canada
- c. Mexico
- Europe
- a. Germany
- b. U.K.
- c. France
- d. Spain
- e. BENELUX
- f. Rest of Europe
- Asia Pacific
- a. China
- b. India
- c. Japan
- d. South Korea
- e. Rest of APAC
- Latin America
- a. Brazil
- b. Rest of LATAM
- Middle East & Africa
- a. Saudi Arabia
- b. UAE
- c. Israel
- d. Rest Of MEA
Latest Published Reports by Emergen Research in Healthcare Industry Segment:
Health Data Archiving Market Size, Share, Trends, By Type (Flash & Solid-State Storage, Magnetic Storage), By Storage System (Direct-Attached Storage, Storage Area Network, Network-Attached Storage), By Deployment, By Architecture, By End-use, and By Region Forecast to 2028.
Gel Documentation System Market By Product Type (Instruments, Software, Accessories), By Light Source (Light-Emitting Diodes, UV, Laser), By Detection Technique (UV Detectors, Fluorescence, Chemiluminescence), By Application (Nucleic Acid Quantification, Protein Quantification, Other Applications), By End-Use (Academic & Research Institutes, Pharma & Biotech Companies, Diagnostic Laboratories), and By Region Forecast to 2028.
Phospholipids Market By Type (Phosphatidic Acid, Phosphatidylglycerol, Phosphatidylethanolamine, and Others), By Product Type (Liquid, Powder, Particles), By Source (Natural, Synthetic), By Function, By Application, and By Region Forecast to 2028.
DNA Origami Market Size, Share, Trends, By Type (Single-stranded Scaffold DNA, Folding Kits, Staple Strand Oligos), By Structure (Static, Active), By Application (Nanorobots and fluorescence studies, Enzyme-substrate studies), and By Region Forecast to 2028.
Cryotherapy Market By Product (Localized Cryotherapy Devices, Cryosurgery Devices, Cryochambers & Cryosaunas, Gas Cylinders, Others), By Therapy (Icepack Therapy, Cryosurgery, Chamber Therapy), By Application, By End-Use, and By Region Forecast.
Fc Fusion Protein Market By Type (Biosimilar Drugs, Brands Drugs), By Therapeutic Area (Eye Diseases, Hemophilia, Autoimmune Disease, Diabetes, Others), By Application (In Vitro, In Vivo), By End-Use (Hospitals, Ophthalmic Hospitals, Oculoplastic Clinics), and By Region Forecast to 2028.
Culture Media Market, By Type, By Research Type, By Application, By End-use, and By Region Forecast to 2028.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release on Biodefense @ https://www.emergenresearch.com/press-release/global-biodefense-market
SOURCE Emergen Research
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article